ReviewTherapeutic advances in neurological disorders2016

An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis.

Pavan Bhargava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.